Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2000-04-27
2004-09-21
Davis, Brian (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C564S503000, C564S506000, C564S452000, C564S453000, C564S454000, C564S246000, C514S636000, C514S659000, C514S660000, C514S671000
Reexamination Certificate
active
06794545
ABSTRACT:
STATEMENT OF RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSORED RESEARCH
Not applicable.
TECHNICAL FIELD
This invention relates to conformationally restricted polyamine analogs, and to porphyrin-polyamine conjugates. This invention also relates to uses of these analogs or conjugates in various medicinal applications, including suppressing cell proliferation and treating various diseases, including cancer.
BACKGROUND OF THE INVENTION
Natural polyamines, e.g., spermidine, norspermidine, homospermidine, 1,4-diaminobutane (putrescine), and spermine, are simple aliphatic amines produced in eukaryotic cells by a highly regulated metabolic apparatus. Polyamine levels and the activity of the polyamine biosynthetic apparatus tend to be high in dividing mammalian cells and low in quiescent cells. Populations of cells depleted of their polyamine content stop growing and may die. Janne et al. (1978)
A. Biochim. Biophys. Acta.
473:241 and Pegg et al. (1982)
Am. J Cell. Physiol.
243:212-221. Polyamines are reviewed in Morgan (1998)
Methods. Mol. Biol.
79:3-30.
Several lines of evidence indicate that polyamines, particularly spermidine, are required for cell proliferation: (i) they are found in greater amounts in growing than in non-growing tissues; (ii) prokaryotic and eukaryotic mutants deficient in polyamine biosynthesis are auxotrophic for polyamines; and (iii) inhibitors specific for polyamine biosynthesis also inhibit cell growth. Despite this evidence, the precise biological role of polyanines in cell proliferation is uncertain. It has been suggested that polyamines, by virtue of their charged nature under physiological conditions and their conformational flexibility, might serve to stabilize macromolecules, such as nucleic acids, by anion neutralization. Hafner et al. (1979)
J. Biol. Chem.
254:12419; Pohjatipelto et al. (1981)
Nature
293:475; Mamont et al. (1978)
Biochem. Biophys. Res. Commun.
81:58; Bloomfield et al. (1981) in
Polyamines in Biology and Medicine
, Morris et al., Eds., Dekker, New York, pp. 183-205.
A treatment approach has been devised based on the observation that increases in the polyamine pool suppress polyamine biosynthesis. Porter et al. (1988) in
Advances in Enzyme Regulation
, Pergamon Press, pp. 57-79. This approach attempts to identify polyamine analogs which down-regulate polyamine biosynthesis, but which do not perform the polyamine functions required for cell growth. BESPM, a N-bis(ethyl) analog of spermine, has served as a model compound for this strategy. BESPM rapidly suppresses polyamine biosynthetic enzymes, depletes natural polyamine pools, and inhibits cell growth in vitro. Porter et al. (1987)
Cancer Res.
47:2821-2825. In addition, BESPM suppresses polyamine uptake (Byers et al. (1990)
J. Physiol.
142:460-467; and Kramer et al. (1993)
J. Cell. Physiol.
115:399-407), and thus minimizes the ability of tumor cells to meet their polyamine requirement by taking them up from their environment. BESPM and related analogs also induce the polyamine metabolizing enzyme spermidine/spermine N
1
-acetyltransferase (SSAT) in certain human carcinoma cell lines.
BESPM and other polyamine analogs have been used, or proposed for use, in treating a large variety of diseases, including a number of different cancers. U.S. Pat. No. 5,541,230. Polyamine analogs demonstrated, for example, potent antitumor activity against several melanoma cell lines and tumors in vitro (Porter et al. (1991)
Cancer Res.
51:3715-3720; Shappell et al. (1992)
Anticancer Res.
12:1083-1090) and in vivo using tumors growing as xenografts in athymic mice (Bernacki et al. (1992)
Cancer Res.
52:2424-2430; Porter et al. (1993)
Cancer Res.
53:581-586). Potent-antitumor activity of bis-ethyl spermine analogs has also been demonstrated for pancreatic cancer cell lines in vitro (Chang et al. (1992)
Cancer Chemother. Pharmacol.
30:183-188) and in vivo (Chang et al. (1992)
Cancer Chemother. Pharmacol.
30:179-182). Polyamine analogs have also been suggested for use in treating brain tumor therapy. Redgate et al. (1995)
J. Neurooncol.
25:167-79. In addition to being useful against cancers of the brain, pancreas, and skin, polyamine analogs are also useful against cancers of the bladder, bone, breast, colon, digestive tract, lung and ovaries. Chang et al. (1993)
J. Urol.
150:1293-7; Snyder et al. (1994)
Anticancer Res.
14:347-56; Yuan et al. (1994)
Biochem. Pharmacol.
47:1587-92; Davidson et al. (1993)
Cancer Res.
53:2071-5; Berchtold et al. (1998)
J. Cell. Physiol.
174 380-6; Porter et al. (1988)
Adv. Exp. Med. Biol.
250:677-90; U.S. Pat. Nos. 5,498,522 and 5,374,658. U.S. Pat. No. 5,498,522 presents the use of spermidine/spermine N
1
-acetyltransferase as a prognostic indicator of the efficacy of a polyamine analog against a malignant tumor.
Polyamine analogs have been used to treat cancer of the prostate. Mi et al. (1988)
Prostate
34:51-60. Polyamines are produced in large amounts by the prostate gland and are abundant in the seminal fluid. Herr et al. (1984)
Cancer
53:1294-8. Polyamine analogs such as BE-4444, BE-373, and BE-333 are particularly effective in inhibiting prostate xenograft tumors in nude mice. Zagaja et al. (1998)
Cancer Chem. Pharm.
41:505-512; Jeffers et al. (1997)
Cancer Chem. Pharm.
40:172-179; Feuerstein et al. (1991)
J. Cell. Biochem.
46:37-47; and Marton et al. (1995)
Ann. Rev. Pharm. Toxicol.
30 35:55-91.
In addition to treating cancer, polyamines and their analogs have uses in treating a number of other diseases and in numerous other medicinal applications. Oxidized polyamines are believed to inhibit growth of parasites (Morgan et al. (1983)
Adv. Polyamine Res.
4: 169-174; Morgan et al. (1986)
Biochem. J
236:97-101; and U.S. Pat. No. 4,935,449) and suppress infectivity of selected strains of bacteria and fungi (Bachrach et al. (1971)
J. Gen. Virol.
13:415-22; Nishimura et al. (1971)
Blochim. Biophys. Acta
247:153-6; and U.S. Pat. No. 5,744,453). Polyamines such as spermine and polyamine analogs are also anti-viral and some are anti-insecticidal. Bachrach et al. (1972)
Appl. Microbiol.
23:232-5; Bachrach et al. (1971)
J Gen. Virol.
11:1-9; U.S. Pat. Nos. 5,021,409; 5,606,053; 5,608,061; 5,612,478; and 5,681,837. In addition, oxidized polyamines, such as spermine dialdehyde, for example, can be used in treatment of tissue grafts and other organs for transplantation. U.S. Pat. No. 5,374,658. Polyamine analogs can also be used to treat neurodegenerative diseases and neurotrauma such as stroke. U.S. Pat. Nos. 5,646,188 and 5,677,349. Polyamine analogs have also been reported to be useful as anti-psoratic agents, and in the treatment of epilepsy, Alzheimer's disease, and multiple sclerosis, as described in U.S. Pat. No. 5,646,188. Polyamine analogs are also useful in treating and preventing restenosis. U.S. Pat. No. 5,516,807. Polyamine analogs are also useful in treatment of gastric ulcers. Igarashi et al. (990)
Biochem. Biophys. Res. Commun.
172:715-20. In addition, polyamine derivatives including N-alkythio polyamine derivatives, polyamine thiols, and polyamine phenols are useful as radioprotective agents for normal tissues during radiotherapy. U.S. Pat. Nos. 5,217,964; 5,354,782; and 5,434,145.
Polyamines and their analogs can be administered alone or in conjunction with additional agents. For example, therapeutic polyamines can be administered along with 1,3-bis (2-chloroethyl)-1-nitrosourea. U.S. Pat. No. 5,541,230. In treating cancer, polyamines can be co-administered with various cytotoxic agents, including antineoplastic vinca alkaloids, antibiotics, antimetabolites, and platinum coordination complexes. U.S. Pat. No. 5,654,287.
In addition to the various aforementioned medicinal uses, polyamines and polyamine analogs have a variety of industrial uses, including derivativization of silica. U.S. Pat. No. 5,763,388. Polyamines have also been used in conjunction with other clarification aids to treat wastewaters. U.S. Pat. Nos. 5,413,719 and 5,707,532. The combination of aluminum chlorohydrate and a poly
Basu Hirak S.
Blokhin Andrei V.
Frydman Benjamin
Marton Laurence J.
Reddy Venodhar K.
Davis Brian
Morrison & Foerster / LLP
SLIL Biomedical Corporation
LandOfFree
Conformationally restricted polyamine analogs as disease... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conformationally restricted polyamine analogs as disease..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conformationally restricted polyamine analogs as disease... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3248819